Neumann Mark
- SEC CIK
- 0001756211
No open-market purchases or sales filed in the past year.
Current role at each company
- MANE Veradermics, IncChief Commercial Officeras of Feb 5, 2026
- ITCI Intra-Cellular Therapies, Inc.EVP, Chief Commercial Officeras of Apr 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Neumann Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ITCI Intra-Cellular Therapies, Inc.
EVP, Chief Commercial Officer16 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 (view filing) | Oct 18 | 1 day | Neumann MarkEVP, Chief Commercial Officer | SSale | −13.4K | $40.86 | −$549.6K | −22.9%45.3K after | 4 lots |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Neumann MarkEVP, Chief Commercial Officer | SSale | −20.9K | $40.78 | −$854.3K | −31.6%45.3K after | 3 lots |
| Feb 23, 2022 (view filing) | Feb 22 | 1 day | Neumann MarkEVP, Chief Commercial Officer | SSale | −11.1K | $55.29 | −$615.8K | −19.7%45.3K after | 2 lots |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Neumann MarkEVP, Chief Commercial Officer | SSale | −7.91K | $52.21 | −$412.8K | −14.8%45.3K after | 3 lots |
| Apr 8, 2022 (view filing) | Apr 8 | Same day | Neumann MarkEVP, Chief Commercial Officer | SSale | −86.3K | $64.37 | −$5.56M | −65.6%45.3K after | 3 lots |
| Feb 22, 2023 (view filing) | Feb 21 | 1 day | Neumann MarkEVP, Chief Commercial Officer | SSale | −3.90K | $47.01 | −$183.2K | −6.9%52.6K after | 3 lots |
| Feb 27, 2023 (view filing) | Feb 24 | 3 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −4.05K | $47.12 | −$190.6K | −6.7%56.4K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −7.24K | $50.01 | −$362.1K | −12.8%49.2K after | |
| Mar 13, 2023 (view filing) | Mar 10-13 | 3 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −12.3K | $43.84 | −$539.6K | −16.8%60.9K after | 4 lots |
| Mar 30, 2023 (view filing) | Mar 28 | 2 days | Neumann MarkEVP, Chief Commercial Officer | SSale | −15.6K | $54.31 | −$847.4K | −25.6%45.3K after | 2 lots10b5-1 |